z-logo
open-access-imgOpen Access
Intramyocardial sustained delivery of placental growth factor using nanoparticles as a vehicle for delivery in the rat infarct model
Author(s) -
Dominique ShumTim,
Arghya Paul,
Afshan Khan,
Satya Prakash
Publication year - 2011
Publication title -
international journal of nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.245
H-Index - 128
eISSN - 1178-2013
pISSN - 1176-9114
DOI - 10.2147/ijn.s25175
Subject(s) - medicine , angiogenesis , placental growth factor , myocardial infarction , proinflammatory cytokine , cardiac function curve , cytokine , in vivo , masson's trichrome stain , cardiology , ischemia , andrology , vascular endothelial growth factor , heart failure , inflammation , immunohistochemistry , biology , microbiology and biotechnology , vegf receptors
Acute myocardial ischemia results in scar formation with ventricular dilatation and eventually heart failure. Placental growth factor (PlGF) is reported to stimulate angiogenesis and improve cardiac function. In this study, it was hypothesized that intramyocardial injection of PlGF contained in nanoparticles can be released at the site of action for an extended time period as a sustained slow-release protective mechanism that accelerates myocardial recovery in a rat model of ischemic cardiomyopathy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom